BiomX Inc. (PHGE)

BiomX Statistics

Total Valuation

BiomX has a market cap or net worth of $13.89 million. The enterprise value is $9.22 million.

Market Cap	13.89M
Enterprise Value	9.22M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

BiomX has 26.55 million shares outstanding. The number of shares has increased by 252.22% in one year.

Current Share Class	26.55M
Shares Outstanding	26.55M
Shares Change (YoY)	+252.22%
Shares Change (QoQ)	+35.52%
Owned by Insiders (%)	5.49%
Owned by Institutions (%)	22.21%
Float	18.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	26.85
P/TBV Ratio	26.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.66, with a Debt / Equity ratio of 0.49.

Current Ratio	2.66
Quick Ratio	2.37
Debt / Equity	0.49
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -79.71% and return on invested capital (ROIC) is -66.63%.

Return on Equity (ROE)	-79.71%
Return on Assets (ROA)	-41.14%
Return on Invested Capital (ROIC)	-66.63%
Return on Capital Employed (ROCE)	-110.43%
Revenue Per Employee	n/a
Profits Per Employee	-$325,737
Employee Count	57
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BiomX has paid $6,000 in taxes.

Income Tax	6,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.12% in the last 52 weeks. The beta is 1.40, so BiomX's price volatility has been higher than the market average.

Beta (5Y)	1.40
52-Week Price Change	-51.12%
50-Day Moving Average	0.50
200-Day Moving Average	0.58
Relative Strength Index (RSI)	52.55
Average Volume (20 Days)	271,242

Short Selling Information

The latest short interest is 370,340, so 1.39% of the outstanding shares have been sold short.

Short Interest	370,340
Short Previous Month	1.55M
Short % of Shares Out	1.39%
Short % of Float	2.05%
Short Ratio (days to cover)	0.86

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-35.10M
Pretax Income	-18.56M
Net Income	-18.57M
EBITDA	-33.33M
EBIT	-35.10M
Earnings Per Share (EPS)	-$2.01

Balance Sheet

The company has $14.05 million in cash and $9.38 million in debt, giving a net cash position of $4.67 million or $0.18 per share.

Cash & Cash Equivalents	14.05M
Total Debt	9.38M
Net Cash	4.67M
Net Cash Per Share	$0.18
Equity (Book Value)	19.16M
Book Value Per Share	0.02
Working Capital	10.37M

Cash Flow

In the last 12 months, operating cash flow was -$29.21 million and capital expenditures -$21,000, giving a free cash flow of -$29.23 million.

Operating Cash Flow	-29.21M
Capital Expenditures	-21,000
Free Cash Flow	-29.23M
FCF Per Share	-$1.10

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BiomX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-252.22%
Shareholder Yield	n/a
Earnings Yield	-133.69%
FCF Yield	-210.45%

Analyst Forecast

The average price target for BiomX is $15.00, which is 2,768.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	2,768.07%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-13.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 26, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	Aug 26, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a